NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/17/2024
Back to search
Official data from USPTO
SYMBIO PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SYMBIO PHARMA
ST13
US500000097917514Class
5, 10
Filing
97917514
Registration
7604073
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
12/17/2024
Trademark type
Word
Nice classes
5, 10
Filing date
05/02/2023
Registration date
12/17/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/17/2024
Last transaction
12/17/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Minato-ku, Tokyo, JP
Examiner
RIRIE, VERNA BETH
Law office
L40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
SymBio Pharmaceuticals Limited
Representatives
Makiko Coffland CHRISTENSEN O'CONNOR JOHNSON KINDNESS
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of viraloncologicalneurological diseases and disorders; pharmaceutical preparationsliquid suspension as drug delivery agents to facilitate the delivery of pharmaceutical preparationsnasal sprays for medical purposes and eye drops; gelatin capsules sold empty for pharmaceuticals; lactose for medical purposes; vectors for gene therapygenetically engineered tissues for transplant purposes; vaccines for gene therapy; reagents for use in medical genetic testing; intravenous fluids used for rehydrationnutrition and the delivery of pharmaceutical preparations; pharmaceutical preparations for the treatment of blood disorder; pharmaceutical preparations for the preventiontreatment and diagnostic of cancer; antitumor drugs; pharmaceuticals being for transdermal infusion patches for the treatment of cancer and nausea; anti-nauseants; gelatin capsules sold empty for medicines; gelatin capsules sold empty for pharmaceuticals; testing and diagnostic preparations for medical purposes; antivirals; cotton swabs for medical use; testing kits comprised of diagnostic reagents and cotton swabs for virus infection; diagnostic kits comprised of diagnostic reagents and cotton swabs for virus infection
Class 10
Medical diagnostic apparatus for testing for viruses
Publications
History of USPTO decisions and trademark events.
19 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/17/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/15/2024
PUBO
PUBLISHED FOR OPPOSITION
10/15/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/25/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/10/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/10/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/10/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/09/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/07/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/07/2024
ALIE
ASSIGNED TO LIE
09/05/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/05/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/06/2024
GNRT
NON-FINAL ACTION E-MAILED
02/06/2024
CNRT
NON-FINAL ACTION WRITTEN
02/06/2024
DOCK
ASSIGNED TO EXAMINER
01/27/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/31/2023
NWAP
NEW APPLICATION ENTERED
05/05/2023
Continuous trademark protection
Get notified about every new filing that threatens SYMBIO PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.